Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over 12,000 men in Sweden.

New technologies can potentially save lives by helping identify prostate cancer earlier, and transforming the way doctors detect and track cancerous cells. Prostate cancer is the most common cancer ...

Q: I am 77. My brother died of prostate cancer. My doctor says I don’t need PSA testing at my age. But because my brother ...

According to the institute, a single, reliable test to differentiate aggressive, life-threatening cancers from slower-growing ...

A new study suggests the investigational Stockholm3 blood test may improve the early detection of aggressive prostate cancer ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, announced today the integration of the ...

"A lot of people assume that if their doctor doesn't bring up prostate cancer screening, it must not be important. But sometimes there just isn't enough time during a visit,” Sh ...

NeoGenomics, Inc.(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of PTEN IHC CDx, the first immunohistochemistry (IHC) ...

The 68-year-old previously told how his diagnosis came as a 'real bolt from the blue' ...

September marks the beginning of National Prostate Cancer Awareness Month in the United States, and statistics show that one ...